LGE for Risk Stratification in Primary Prevention in Children With HCM

Sudden cardiac death is the most visible, devastating, and unpredictable consequence of hypertrophic cardiomyopathy (HCM) in young patients ([1][1]). The recommended risk stratification approaches for childhood HCM have remained largely unchanged for more than 2 decades, with the treatment relying